Browsing: Industry

The global GLP-1 market revenue surpassed USD 58.40 billion in 2025 and is predicted to attain around USD 212.73 billion by 2035, growing at a CAGR of 13.80%. The market is driven by the increasing prevalence of obesity and type 2 diabetes throughout the world, the effectiveness of GLP-1 agonists in terms of significant weight…

The Technology Licensing Office’s bi-weekly market research report highlights emerging trends, market signals, and industry developments that may inform research and commercialization strategy across the University of Utah. Each edition curates timely insights from key sectors to help faculty, researchers, and innovation partners identify opportunities, anticipate market needs, and align discoveries with real-world demand